Tag: life sciences
-

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test
Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors.
-

Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test
A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria.
-

Patent Issued for Crispr-Edited Viruses in Microbiome
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments.
-

Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-

Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-

Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-

Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.
-

NIH Funds Decentralized Rare Disease Data Network
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency.
-

Trial Underway Assessing Gut Microbiome-Cancer Links
A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer.
-

Challenge Seeks Animal-Free Testing for Precision Meds.
A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine.